Artiva Biotherapeutics Files IPO Plans Plus 13D & 13G Filing Update

July 04, 2024

Stephen Taub gives a round-up of interesting SEC filings (II Research subscribers only)

Enter your email to login or subscribe now:

II Research subscribers enjoy more

Top-line results
Access to data archive
Weekly articles from Stephen Taub

Subscribe Think you’re receiving this message in error? Contact Us

Topics

biotechnology SEC Filings Biopharm healthcare Industrials Hedge Funds

Stephen Taub